Skip to content

Drug interactions

Cabazitaxel + Efavirenz

Severity: Moderate

Cabazitaxel and Efavirenz: moderate interaction.

Last updated

For healthcare professionals — reference only. This page is a brief summary, not medical advice and not a substitute for official labeling or clinical judgement. Always verify before prescribing or dispensing.

Summary

Cabazitaxel is metabolised mainly by CYP3A4, so efavirenz as an inducer is expected to reduce its exposure and possibly its efficacy. The legacy direction of effect is the opposite of what induction predicts.

What this interaction means in plain words

Cabazitaxel and Efavirenz can affect each other. The combination is often manageable, but it may need a change of dose, a change of timing, or extra checks while both are taken.

Cabazitaxel belongs to Oncology; Efavirenz belongs to Anti Virals.

Evidence level: Low

Why it happens

Efavirenz induction of CYP3A4 increases cabazitaxel clearance.

What to do

Cabazitaxel labeling advises avoiding strong CYP3A inducers where possible. Consider a non-inducing antiretroviral and monitor treatment response.

What to ask your pharmacist

  • Should I take them at different times of day?
  • Does the dose of either medicine need to change?
  • Is there anything I should avoid, such as alcohol or certain foods, while on both?

Bring a full list of your medicines, including over-the-counter products, supplements and herbal remedies, to every pharmacy visit.

Pro+ members

Unlock the full page

Create an account and start a Pro+ trial to unlock the full management advice for Cabazitaxel and Efavirenz, the additional notes, the evidence detail and the whole-prescription interaction checker.

  • Full clinical management advice
  • Additional notes
  • Evidence detail
  • Interaction checker for a whole prescription

Try Pro+ free for 14 days on the web. No card needed.

Frequently asked questions

Can I take Cabazitaxel with Efavirenz?

MediHelp rates the interaction as moderate. Cabazitaxel and Efavirenz can affect each other. The combination is often manageable, but it may need a change of dose, a change of timing, or extra checks while both are taken. Cabazitaxel is metabolised mainly by CYP3A4, so efavirenz as an inducer is expected to reduce its exposure and possibly its efficacy. The legacy direction of effect is the opposite of what induction predicts.

How serious is the interaction between Cabazitaxel and Efavirenz?

MediHelp rates it moderate, on a four-level scale (minor, moderate, major, contraindicated) based on published labels and references. What to do, in brief: Cabazitaxel labeling advises avoiding strong CYP3A inducers where possible. Consider a non-inducing antiretroviral and monitor treatment response.

What other medicines interact with Efavirenz?

MediHelp also lists interactions of Efavirenz with, for example, Cobimetinib, Dienogest / estradiol valerate, Dihydroergotamine intranasal. The full list is on the Efavirenz page.

Full monographs, dosing and an interaction checker in the MediHelp app

Open the complete reference, check multi-drug interactions and use dosing tools in the MediHelp app.

Browse A–Z · Drug interactions

Get the app Sign in